A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)
Clinical trial NCT01717287 · COMPLETED
Trial details
- NCT number
- NCT01717287
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-16
- Primary completion
- 2013-12-11
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.